Several studies have consistently demonstrated that aberrant upregulation of PCAT6 is common in lung cancer tissues and promotes the proliferation, migration, and invasion of lung cancer cells (Wan et al., 2016; Cui et al., 2018; Shi X. et al., 2018). Here, PCAT6 is linked to lung cancer.